K062217Substantially Equivalent
Aeskulska Beta2-Glyco-a
Aesku, Inc., Miami FL / Traditional, Substantially Equivalent
K062217 is the FDA 510(k) clearance record for AESKULSKA BETA2-GLYCO-A, a class II device, cleared for Aesku, Inc. on under FDA product code MSV (System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi)). FDA records list 6 510(k) clearances for Aesku, Inc., from to . As of , FDA records show no recalls naming K062217.
Clearance record
- Decision date
- Received
- (134 days to decision)
- Product code
- MSV System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi)
- Regulation
- 21 CFR 866.5660
- Device class
- Class II
- Review panel
- Immunology
- Applicant
- Aesku, Inc. 8880 Northwest 18th Ter., Miami FL
- 510(k) summary
- Summary PDF
- Third party review
- No
Clearances, product code MSV
Trailing 12 monthsShow the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 1 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
